Where does Axsome Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Axsome Therapeutics, Inc. ranks #2,984 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Axsome Therapeutics, Inc. hold?

Axsome Therapeutics, Inc. holds 127 US utility patents granted between 2017 and 2025, spanning 6 technology areas.

What is Axsome Therapeutics, Inc.'s Innovation Score?

Axsome Therapeutics, Inc. has an Innovation Score of 44.2 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Axsome Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Axsome Therapeutics, Inc.'s recent grant velocity is +330% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Axsome Therapeutics, Inc.'s patents?

Axsome Therapeutics, Inc.'s patents average 23.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Axsome Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Axsome Therapeutics, Inc.

Q: What technology areas does Axsome Therapeutics, Inc. focus on?

Axsome Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 127 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 127 granted patents across 6 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Axsome ranks #2,984 of 49,997 tracked US assignees by granted-patent volume, with 127 patents across 6 technology areas.

#2,984
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.2/100): 23.9
avg claims per patent: +330%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2984 · US Corporation #2,984 · 127 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 127 grants
TOP-DECILE #2,984/49,997
PHOTO-FINISH ABB Power Grids…
CPC-NARROW A61K · 6 areas
INNOV-PAR 44.2/100
CLAIMS-DENSE 23.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +330% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ABB Power Grids Switzerland AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Axsome Therapeutics · this assignee

44
Biomet Biologics · near

44
Decision Sciences… · near

44
Gibbs · near

44
Mitek Systems · near

44
3D Lighting… · lowest

7

What this shows Axsome's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Axsome's grants concentrate

Axsome Therapeutics, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (26 grants) versus a trough of 1 in 2017. By volume, Axsome sits between Vrije Universiteit Brussel and Dana Canada Corporation.

Axsome's three-year grant acceleration

From 2019–2021 to 2022–2024, Axsome Therapeutics, Inc. moved from 71 to 48 grants (0.68x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,224. See the growth leaderboard.

Vrije Universitei…

128
simplehuman

128
ABB Power Grids S…

127
Albea Services

127
Basell Polyolefine

127
Centre National d…

127
Corning Cable Sys…

127
Dana Canada

127
Axsome Therapeuti… ◀

127

What this shows Axsome holds 127 patents at rank #2,984, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Axsome

By rank, the assignees closest to #2,984 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Axsome's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Axsome, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Biomet Biologics, LLC 44 Mitek Systems, Inc. 44 Decision Sciences International Corporation 44 Gibbs Technologies Limited 44

Similar claim depth

Nearest assignees by average claims per patent (23.9 here).

Audible, Inc. 23.9 avg MKS Instruments, Inc. 23.9 avg ExtraHop Networks, Inc. 23.9 avg Global Graphene Group, Inc. 23.8 avg

Axsome's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Axsome Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	0.8%
2018	2	1.6%
2019	20	15.7%
2020	25	19.7%
2021	26	20.5%
2022	22	17.3%
2023	16	12.6%
2024	10	7.9%
2025partial year	5	3.9%

Which technologies does Axsome Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 127

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 95

C08B - POLYSACCHARIDES; Derivatives Thereof 72

C08L - Compositions OF Macromolecular Compounds 22

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#2,984

of 49,997 tracked assignees

Innovation Score

44.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Axsome Therapeutics, Inc.'s patent record in context - here's where to go next.

Axsome Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #2,984 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Axsome Therapeutics, Inc. against Vrije Universiteit Brussel, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.